Chapter 1: Assessing Need for Treatment of Central Precocious Puberty
Marcela Vargas Trujillo, MD, and Karen Klein, MD, introduce Chloé, a hypothetical patient with central precocious puberty. They discuss standard treatment with GnRHa therapy and whether Chloé’s specific measurements indicate potential benefit with therapy initiation.
Karen O. Klein, MD
Pediatric Endocrinologist,
Rady Children’s Hospital - San Diego
Clinical Professor of Pediatrics
UC San Diego School of Medicine
San Diego, California
Marcela Vargas Trujillo, MD
Pediatric Endocrinologist,
Rady Children’s Hospital - San Diego
Associate Professor of Pediatrics
UC San Diego School of Medicine
San Diego, California
Review a patient case regarding a girl with central precocious puberty (CPP) and discuss an individualized treatment approach guided by recent analysis of clinical trial data
Examine the multiple factors that should be considered when deciding to initiate or discontinue CPP treatment
Discuss some of the limitation of current approaches to CPP treatment initiation and cessation
Highlight the importance of discontinuing treatment at the appropriate age of onset of puberty
"Recognizing the Signs of Central Precocious Puberty (CPP) Earlier: Journey from Patient to Referral Through Case Studies"
https://www.contemporarypediatrics.com/view/cpp